Fosun Pharma Conducted Human Safety Trials for Pfizer's mRNA Vaccines in China. Guess How China Responded to the Data?
After completing Pfizer's initial mRNA human safety trials, China banned Pfizer's mRNA technology for use in Chinese citizens. The FDA authorized Pfizer's mRNA as safe for U.S. citizens.
May 12, 2023: According to the NIH clinical trial database, Chinese biotech $44 billion dollar giant, Fosun Pharma, conducted the initial Pfizer/BioNTech Phase-1 human safety trials in 144 civilians in China. After Fosun Pharma completed their clinical evaluation of the safety of Pfizer’s mRNA vaccines for human use, China banned Pfizer's mRNA lipid nanoparticle technology for use in Chinese citizens.
That’s worth repeating.
Keep reading with a 7-day free trial
Subscribe to The Kingston Report to keep reading this post and get 7 days of free access to the full post archives.